002566 Jilin Jian Yisheng Pharmaceutical
- 6.95
- +0.16+2.36%
Jilin Jian Yisheng Pharmaceutical News
Yisheng Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Yisheng Pharmaceutical: Announcement of Supervisory Committee Resolutions
Yisheng Pharmaceutical: Announcement of Board Resolutions
Yisheng Pharmaceutical: Report for the third quarter of 2024
Yisheng Pharmaceutical: Progress Notice on Using Idle Own Funds to Purchase Wealth Management Products
Yisheng Pharmaceutical: Notice on Using Idle Own Funds to Purchase Wealth Management Products for Expiration and Redemption
Jilin Jian Yisheng Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Jilin Jian Yisheng Pharmaceutical: Financial Report for the first half of 2024.
Jilin Jian Yisheng Pharmaceutical: Half-year report for the year 2024.
Jilin Jian Yisheng Pharmaceutical: Summary of Half-Year Report in 2024.
Jilin Jian Yisheng Pharmaceutical: Announcement regarding the use of idle self-owned funds to purchase financial products, redeem at maturity, and continue to purchase financial products.
Jilin Jian Yisheng Pharmaceutical: 002566 Yisheng Pharmaceutical Investor Relations Management Information 20240530
Jilin Jian Yisheng Pharmaceutical: Announcement on attending the online group results briefing
Jilin Jian Yisheng Pharmaceutical: Progress Notice on Using Idle Own Funds to Purchase Wealth Management Products
Jilin Jian Yisheng Pharmaceutical: Notice on Using Idle Own Funds to Purchase Wealth Management Products
Jilin Jian Yisheng Pharmaceutical: Announcement of Resolutions of the 13th Meeting of the Eighth Board of Supervisors
Jilin Jian Yisheng Pharmaceutical: Announcement of Resolutions of the 13th Meeting of the Eighth Board of Directors
Jilin Jian Yisheng Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Jilin Jian Yisheng Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Jilin Jian Yisheng Pharmaceutical: Legal Opinion of Beijing Zhide Law Firm on the 2023 Annual General Meeting of Shareholders of Jilin Ji'an Yisheng Pharmaceutical Co., Ltd.
Analysis
Price Target
No Data
No Data